Medicines Discovery Catapult (MDC), the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) are partnering to deliver The State of the Discovery Nation 2023 (SODN2023) report. This report looks at how the sector has evolved over the last five years and the current challenges facing the community.
MDC, ABPI and BIA have commissioned 7i Group, an independent market research agency, to conduct the underpinning research for the report.
As part of this work, 7i Group is surveying organisations active in drug discovery and development to understand the changing nature of the sector.
The information gathered in this survey will be analysed in aggregate to create a report which will be published and publicly accessible. No information will be attributed to individual companies.
This survey will take no longer than 10 minutes to complete.
Your feedback will be invaluable – helping illuminate the challenges and opportunities the sectors face and raising the profile of each.
There is an option to participate in a subsequent, more detailed conversation, building on the themes put forward in the survey.
The deadline for the survey is Friday, 21st April.
We thank you in advance for your support.
The link to the survey is here:
Investment and expert support will help accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases.
The centre will provide integrated expertise and evidence generation to help innovators accelerate the development of next-generation RNA medicines.
